MAINZ BIOMED N.V. Quarterly Research And Development Expense in USD from Q1 2022 to Q4 2023

Taxonomy & unit
ifrs-full: USD
Summary
Mainz Biomed N.V. quarterly/annual Research And Development Expense history and growth rate from Q1 2022 to Q4 2023.
  • Mainz Biomed N.V. Research And Development Expense for the quarter ending December 31, 2023 was $1.63M, a 50.8% decline year-over-year.
  • Mainz Biomed N.V. Research And Development Expense for the twelve months ending December 31, 2023 was $9.59M, a 91.1% increase year-over-year.
  • Mainz Biomed N.V. annual Research And Development Expense for 2023 was $9.59M, a 91.1% increase from 2022.
  • Mainz Biomed N.V. annual Research And Development Expense for 2022 was $5.02M, a 942% increase from 2021.
  • Mainz Biomed N.V. annual Research And Development Expense for 2021 was $482K, a 54.5% increase from 2020.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $9.59M $1.63M -$1.68M -50.8% Oct 1, 2023 Dec 31, 2023 20-F 2024-04-09
Q3 2023 $11.3M $1.85M +$946K +104% Jul 1, 2023 Sep 30, 2023 6-K 2023-11-16
Q2 2023 $10.3M $3.48M +$3.25M +1413% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-15
Q1 2023 $7.08M $2.63M +$2.06M +366% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-16
Q4 2022 $5.02M $3.32M Oct 1, 2022 Dec 31, 2022 20-F 2024-04-09
Q3 2022 $909K Jul 1, 2022 Sep 30, 2022 6-K 2023-11-16
Q2 2022 $230K Apr 1, 2022 Jun 30, 2022 6-K 2023-08-15
Q1 2022 $564K Jan 1, 2022 Mar 31, 2022 6-K 2023-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.